Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Clinical Genetics, |
RCV003238147 | SCV002010397 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002503255 | SCV002799782 | uncertain significance | X-linked intellectual disability with marfanoid habitus; FG syndrome 1; Cholestasis-pigmentary retinopathy-cleft palate syndrome; Blepharophimosis - intellectual disability syndrome, MKB type | 2022-04-25 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003985518 | SCV004103468 | uncertain significance | MED12-related disorder | 2022-08-26 | criteria provided, single submitter | clinical testing | The MED12 c.439G>A variant is predicted to result in the amino acid substitution p.Ala147Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0054% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/X-70339906-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Invitae | RCV003772106 | SCV004686753 | benign | FG syndrome | 2023-07-12 | criteria provided, single submitter | clinical testing |